PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer

Summary

A prospective, nationwide, implementation program of the international standard of excellence for locally advanced pancreatic cancer (LAPC) care in the Netherlands (2021\[7\]-2030\[6\]), including a multidisciplinary training program by the four leading international expert centers.

The PREOPANC-4 project aims a safe and patient-centered implementation of the international standards of excellence for LAPC (surgery) in the Netherlands.

Conditions

• Pancreatic Cancer
• Locally Advanced Pancreatic Adenocarcinoma
• Pancreatic Adenocarcinoma Non-resectable
• Chemotherapy Effect

Interventions

OTHER

Implementation - International best-practice care

The PREOPANC-4 project aims to safely implement the international standard of excellence for LAPC management and surgery using a multidisciplinary best-practice training program, based on the experiences of four leading international expert centers (i.e. NYU Langone Health, University of Colorado, Heidelberg University, and MD Anderson Cancer Center). We hypothesize that the PREOPANC-4 implementation project will result in the improvement in multidisciplinary patient management and selection in line with current international best-practice.

Sponsors & Collaborators

• UMC Utrecht

  collaborator OTHER

• Erasmus Medical Center

  collaborator OTHER

• Leiden University Medical Center

  collaborator OTHER

• University Medical Center Groningen

  collaborator OTHER

• Radboud University Medical Center

  collaborator OTHER

• Maastricht University Medical Center

  collaborator OTHER

• Medisch Spectrum Twente

  collaborator OTHER

• Isala

  collaborator OTHER

• Frisius Medisch Centrum

  collaborator OTHER

• Onze Lieve Vrouwe Gasthuis

  collaborator OTHER

• Amphia ziekenhuis

  collaborator UNKNOWN

• Jeroen Bosch Ziekenhuis

  collaborator OTHER

• Catharina Ziekenhuis Eindhoven

  collaborator OTHER

• University of Colorado, Denver

  collaborator OTHER

• Heidelberg University

  collaborator OTHER

• M.D. Anderson Cancer Center

  collaborator OTHER

• NYU Langone Health

  collaborator OTHER

• Dutch Cancer Society

  collaborator OTHER

• Maag Lever Darm Stichting

  collaborator OTHER

• Deltaplan Alvleesklierkanker

  collaborator UNKNOWN

• Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

  lead OTHER

Principal Investigators

• Marc G Besselink, MD, MSc, PhD · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-07-01

Primary Completion

2024-12-31

Completion

2030-12-31

Countries

• Netherlands

Study Locations